Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Low-dose methotrexate is generally safe but can cause mild to severe side effects, and folic acid can reduce these risks.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Lichen planus may be associated with a higher risk of metabolic syndrome.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Low dose methotrexate does not increase hair fall and may reduce it.

BMAL1 controls skin cell growth and UV damage risk, peaking at night.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

People with Behçet's disease can develop life-threatening lung artery aneurysms that may require surgery.

The mutant HR bmh protein mis-localizes in cells, affecting skin and hair development.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

The demineralized bone matrix scaffold is better for cell attachment than the mineralized bone allograft.

PBM helps improve cell survival in 3D tissue engineering.

Photobiomodulation effectively improves skin and hair conditions with minimal side effects.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

A gene called BMAL1 plays a role in controlling hair growth.

BMS-470539 reduces skin fibrosis and inflammation.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

A man had bad reactions to a hair loss treatment called DNCB.